{"actionType":"INHIBITOR","mechanismOfAction":"Cyclooxygenase inhibitor","chemblIds":["CHEMBL1021"],"targetName":"Cyclooxygenase","targetType":"protein family","targets":["ENSG00000073756","ENSG00000095303"],"references":[{"source":"DailyMed","ids":["setid=6c212466-ff8d-ecfc-ede2-ef8bdcaaf114"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6c212466-ff8d-ecfc-ede2-ef8bdcaaf114"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Glucagon-like peptide 1 receptor agonist","chemblIds":["CHEMBL2108724"],"targetName":"Glucagon-like peptide 1 receptor","targetType":"single protein","targets":["ENSG00000112164"],"references":[{"source":"PubMed","ids":["22918257","24608440"],"urls":["http://europepmc.org/abstract/MED/22918257","http://europepmc.org/abstract/MED/24608440"]}]}
{"actionType":"STABILISER","mechanismOfAction":"Tubulin stabiliser","chemblIds":["CHEMBL96172"],"targetName":"Tubulin","targetType":"protein complex group","targets":["ENSG00000188229","ENSG00000101162","ENSG00000198033","ENSG00000127824","ENSG00000258947","ENSG00000167552","ENSG00000104833","ENSG00000261456","ENSG00000196230","ENSG00000123416","ENSG00000167553","ENSG00000152086","ENSG00000137267","ENSG00000137285","ENSG00000176014"],"references":[{"source":"PubMed","ids":["15123284","15714588","18095749","7757983"],"urls":["http://europepmc.org/abstract/MED/15123284","http://europepmc.org/abstract/MED/15714588","http://europepmc.org/abstract/MED/18095749","http://europepmc.org/abstract/MED/7757983"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Beta-2 adrenergic receptor agonist","chemblIds":["CHEMBL3545272"],"targetName":"Beta-2 adrenergic receptor","targetType":"single protein","targets":["ENSG00000169252"],"references":[{"source":"Other","ids":["http://www.almirall.com/en/about-almirall/research-and-development/pipeline","http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767","http://www.almirall.com/en/about-almirall/research-and-development/pipeline","http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767"],"urls":["http://www.almirall.com/en/about-almirall/research-and-development/pipeline","http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767","http://www.almirall.com/en/about-almirall/research-and-development/pipeline","http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3767"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase PIM inhibitor","chemblIds":["CHEMBL1952329"],"targetName":"Serine/threonine-protein kinase PIM","targetType":"protein family","targets":["ENSG00000137193","ENSG00000102096","ENSG00000198355"],"references":[{"source":"PubMed","ids":["19825806","21628411"],"urls":["http://europepmc.org/abstract/MED/19825806","http://europepmc.org/abstract/MED/21628411"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Dopamine D3 receptor agonist","chemblIds":["CHEMBL1009"],"targetName":"Dopamine D3 receptor","targetType":"single protein","targets":["ENSG00000151577"],"references":[{"source":"DailyMed","ids":["setid=3c768639-8a70-4d12-ad93-827bb42ec6b7"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3c768639-8a70-4d12-ad93-827bb42ec6b7"]},{"source":"Wikipedia","ids":["Levodopa#Biological_role"],"urls":["http://en.wikipedia.org/wiki/Levodopa#Biological_role"]},{"source":"PubMed","ids":["11978145","18549347","9633680"],"urls":["http://europepmc.org/abstract/MED/11978145","http://europepmc.org/abstract/MED/18549347","http://europepmc.org/abstract/MED/9633680"]}]}
{"actionType":"SEQUESTERING AGENT","mechanismOfAction":"Bile acids sequestering agent","chemblIds":["CHEMBL1201474"],"references":[{"source":"DailyMed","ids":["setid=21b37725-fc0c-4365-a7dc-1a473d42502d#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=21b37725-fc0c-4365-a7dc-1a473d42502d#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial penicillin-binding protein inhibitor","chemblIds":["CHEMBL1200356"],"targetName":"Bacterial penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"PubMed","ids":["7447421"],"urls":["http://europepmc.org/abstract/MED/7447421"]},{"source":"Wikipedia","ids":["Penicillin_binding_proteins#Function"],"urls":["http://en.wikipedia.org/wiki/Penicillin_binding_proteins#Function"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H2 receptor antagonist","chemblIds":["CHEMBL1742471"],"targetName":"Histamine H2 receptor","targetType":"single protein","targets":["ENSG00000113749"],"references":[{"source":"PubMed","ids":["10551387","10574469","8736619","9688464","10551387","10574469","8736619","9688464"],"urls":["http://europepmc.org/abstract/MED/10551387","http://europepmc.org/abstract/MED/10574469","http://europepmc.org/abstract/MED/8736619","http://europepmc.org/abstract/MED/9688464","http://europepmc.org/abstract/MED/10551387","http://europepmc.org/abstract/MED/10574469","http://europepmc.org/abstract/MED/8736619","http://europepmc.org/abstract/MED/9688464"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Androgen Receptor agonist","chemblIds":["CHEMBL1200946"],"targetName":"Androgen Receptor","targetType":"single protein","targets":["ENSG00000169083"],"references":[{"source":"PubMed","ids":["18809391"],"urls":["http://europepmc.org/abstract/MED/18809391"]}]}
{"actionType":"SEQUESTERING AGENT","mechanismOfAction":"Rivaroxaban sequestering agent","chemblIds":["CHEMBL3301583"],"references":[{"source":"FDA","ids":["https://www.fda.gov/media/113279/download","https://www.fda.gov/media/113279/download","https://www.fda.gov/media/113279/download"],"urls":["https://www.fda.gov/media/113279/download","https://www.fda.gov/media/113279/download","https://www.fda.gov/media/113279/download"]},{"source":"EMA","ids":["https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya","https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya","https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya"],"urls":["https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya","https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya","https://www.ema.europa.eu/en/medicines/human/EPAR/ondexxya"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Sigma opioid receptor antagonist","chemblIds":["CHEMBL2106217","CHEMBL87493"],"targetName":"Sigma opioid receptor","targetType":"single protein","targets":["ENSG00000147955"],"references":[{"source":"PubMed","ids":["25965391","26600876","27364433","28428755","25965391","26600876","27364433","28428755","25965391","26600876","27364433","28428755"],"urls":["http://europepmc.org/abstract/MED/25965391","http://europepmc.org/abstract/MED/26600876","http://europepmc.org/abstract/MED/27364433","http://europepmc.org/abstract/MED/28428755","http://europepmc.org/abstract/MED/25965391","http://europepmc.org/abstract/MED/26600876","http://europepmc.org/abstract/MED/27364433","http://europepmc.org/abstract/MED/28428755","http://europepmc.org/abstract/MED/25965391","http://europepmc.org/abstract/MED/26600876","http://europepmc.org/abstract/MED/27364433","http://europepmc.org/abstract/MED/28428755"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Integrin alpha-V/beta-3 inhibitor","chemblIds":["CHEMBL1201584"],"targetName":"Integrin alpha-V/beta-3","targetType":"protein complex","targets":["ENSG00000259207","ENSG00000138448"],"references":[{"source":"DailyMed","ids":["setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3","setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=033d4c3b-4630-4256-b8f7-9ed5f15de9a3"]},{"source":"PubMed","ids":["10708709"],"urls":["http://europepmc.org/abstract/MED/10708709"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"B-lymphocyte antigen CD20 binding agent","chemblIds":["CHEMBL2109665"],"targetName":"B-lymphocyte antigen CD20","targetType":"single protein","targets":["ENSG00000156738"],"references":[{"source":"PubMed","ids":["24594909"],"urls":["http://europepmc.org/abstract/MED/24594909"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Proheparin-binding EGF-like growth factor inhibitor","chemblIds":["CHEMBL2109437"],"targetName":"Proheparin-binding EGF-like growth factor","targetType":"single protein","targets":["ENSG00000113070"],"references":[{"source":"PubMed","ids":["26464296","26507836"],"urls":["http://europepmc.org/abstract/MED/26464296","http://europepmc.org/abstract/MED/26507836"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Complement C5 inhibitor","chemblIds":["CHEMBL2107979"],"targetName":"Complement C5","targetType":"single protein","targets":["ENSG00000106804"],"references":[]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL2364635","CHEMBL298470"],"references":[{"source":"Other","ids":["https://gtr.ukri.org/projects?ref=MR/L000644/1"],"urls":["https://gtr.ukri.org/projects?ref=MR/L000644/1"]},{"source":"FDA","ids":["label/2018/210795s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210795s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1200475","CHEMBL178"],"references":[{"source":"Wikipedia","ids":["Daunorubicin","Daunorubicin"],"urls":["http://en.wikipedia.org/wiki/Daunorubicin","http://en.wikipedia.org/wiki/Daunorubicin"]},{"source":"DailyMed","ids":["archiveid=215669","archiveid=69731","archiveid=215669","archiveid=69731"],"urls":["http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=215669","http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=69731","http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=215669","http://www.dailymed.nlm.nih.gov/dailymed/archives/fdaDrugInfo.cfm?archiveid=69731"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Angiotensin-converting enzyme inhibitor","chemblIds":["CHEMBL1201011","CHEMBL1592"],"targetName":"Angiotensin-converting enzyme","targetType":"single protein","targets":["ENSG00000159640"],"references":[{"source":"DailyMed","ids":["setid=26614f0c-7187-4acf-805f-9e5c2bdfff7a"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26614f0c-7187-4acf-805f-9e5c2bdfff7a"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL998"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"PubMed","ids":["2568212"],"urls":["http://europepmc.org/abstract/MED/2568212"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Platelet-derived growth factor receptor inhibitor","chemblIds":["CHEMBL3039504","CHEMBL502835"],"targetName":"Platelet-derived growth factor receptor","targetType":"protein complex","targets":["ENSG00000113721","ENSG00000134853"],"references":[{"source":"FDA","ids":["label/2014/205832s000lbl.pdf","label/2014/205832s000lbl.pdf","label/2014/205832s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205832s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fibroblast growth factor receptor 1 inhibitor","chemblIds":["CHEMBL1980391"],"targetName":"Fibroblast growth factor receptor 1","targetType":"single protein","targets":["ENSG00000077782"],"references":[{"source":"PubMed","ids":["21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658","21553286","24900658"],"urls":["http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658","http://europepmc.org/abstract/MED/21553286","http://europepmc.org/abstract/MED/24900658"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor 2 inhibitor","chemblIds":["CHEMBL3984441"],"targetName":"Vascular endothelial growth factor receptor 2","targetType":"single protein","targets":["ENSG00000128052"],"references":[{"source":"Other","ids":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755"],"urls":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755"]}]}
{"actionType":"SEQUESTERING AGENT","mechanismOfAction":"Ergosterol sequestering agent","chemblIds":["CHEMBL267345"],"references":[{"source":"PubMed","ids":["19689243"],"urls":["http://europepmc.org/abstract/MED/19689243"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Synaptic vesicular amine transporter inhibitor","chemblIds":["CHEMBL2364639"],"targetName":"Synaptic vesicular amine transporter","targetType":"single protein","targets":["ENSG00000165646"],"references":[{"source":"PubMed","ids":["26346941"],"urls":["http://europepmc.org/abstract/MED/26346941"]}]}
{"actionType":"RNAI INHIBITOR","mechanismOfAction":"5-aminolevulinate synthase mRNA RNAi inhibitor","chemblIds":["CHEMBL4297760"],"targetName":"5-aminolevulinate synthase mRNA","targetType":"nucleic-acid","targets":["ENSG00000023330"],"references":[{"source":"FDA","ids":["label/2019/0212194s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/0212194s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Receptor protein-tyrosine kinase erbB-2 inhibitor","chemblIds":["CHEMBL3989921","CHEMBL180022"],"targetName":"Receptor protein-tyrosine kinase erbB-2","targetType":"single protein","targets":["ENSG00000141736"],"references":[{"source":"FDA","ids":["label/2017/208051s000lbl.pdf","label/2017/208051s000lbl.pdf","label/2017/208051s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208051s000lbl.pdf"]},{"source":"PubMed","ids":["15715478","26089701","15715478","26089701","15715478","26089701"],"urls":["http://europepmc.org/abstract/MED/15715478","http://europepmc.org/abstract/MED/26089701","http://europepmc.org/abstract/MED/15715478","http://europepmc.org/abstract/MED/26089701","http://europepmc.org/abstract/MED/15715478","http://europepmc.org/abstract/MED/26089701"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"T cell surface glycoprotein CD3 binding agent","chemblIds":["CHEMBL4298092"],"targetName":"T cell surface glycoprotein CD3","targetType":"protein complex","targets":["ENSG00000198851","ENSG00000160654","ENSG00000167286"],"references":[{"source":"Other","ids":["https://ascopubs.org/doi/full/10.1200/JCO.20.03175","https://ascopubs.org/doi/full/10.1200/JCO.20.03175"],"urls":["https://ascopubs.org/doi/full/10.1200/JCO.20.03175","https://ascopubs.org/doi/full/10.1200/JCO.20.03175"]}]}
{"mechanismOfAction":"Diagnostic agent","chemblIds":["CHEMBL2108800"],"references":[{"source":"FDA","ids":["label/2012/103608s5043lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103608s5043lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Farnesyl diphosphate synthase inhibitor","chemblIds":["CHEMBL924"],"targetName":"Farnesyl diphosphate synthase","targetType":"single protein","targets":["ENSG00000160752"],"references":[{"source":"FDA","ids":["label/2011/021817s012lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021817s012lbl.pdf"]},{"source":"PubMed","ids":["11160603","15028820","16006204","16835450"],"urls":["http://europepmc.org/abstract/MED/11160603","http://europepmc.org/abstract/MED/15028820","http://europepmc.org/abstract/MED/16006204","http://europepmc.org/abstract/MED/16835450"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Frizzled-8 antagonist","chemblIds":["CHEMBL2364652"],"targetName":"Frizzled-8","targetType":"single protein","targets":["ENSG00000177283"],"references":[{"source":"PubMed","ids":["22753465","22753465","22753465","22753465","22753465"],"urls":["http://europepmc.org/abstract/MED/22753465","http://europepmc.org/abstract/MED/22753465","http://europepmc.org/abstract/MED/22753465","http://europepmc.org/abstract/MED/22753465","http://europepmc.org/abstract/MED/22753465"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Gonadotropin-releasing hormone receptor antagonist","chemblIds":["CHEMBL3668014"],"targetName":"Gonadotropin-releasing hormone receptor","targetType":"single protein","targets":["ENSG00000109163"],"references":[{"source":"Other","ids":["http://www.kissei.co.jp/e_contents/rd/pipeline/index.html"],"urls":["http://www.kissei.co.jp/e_contents/rd/pipeline/index.html"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Fibroblast activation protein alpha binding agent","chemblIds":["CHEMBL2109643"],"targetName":"Fibroblast activation protein alpha","targetType":"single protein","targets":["ENSG00000078098"],"references":[{"source":"PubMed","ids":["11259992"],"urls":["http://europepmc.org/abstract/MED/11259992"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Casein kinase II alpha inhibitor","chemblIds":["CHEMBL1230165"],"targetName":"Casein kinase II alpha","targetType":"single protein","targets":["ENSG00000101266"],"references":[{"source":"PubMed","ids":["21159648"],"urls":["http://europepmc.org/abstract/MED/21159648"]}]}
{"actionType":"RELEASING AGENT","mechanismOfAction":"Dopamine transporter releasing agent","chemblIds":["CHEMBL1200782","CHEMBL612"],"targetName":"Dopamine transporter","targetType":"single protein","targets":["ENSG00000142319"],"references":[{"source":"PubMed","ids":["16122767","19244097","7869099","17239355","19727679","15955613","7751968"],"urls":["http://europepmc.org/abstract/MED/16122767","http://europepmc.org/abstract/MED/19244097","http://europepmc.org/abstract/MED/7869099","http://europepmc.org/abstract/MED/17239355","http://europepmc.org/abstract/MED/19727679","http://europepmc.org/abstract/MED/15955613","http://europepmc.org/abstract/MED/7751968"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL1874750"],"references":[{"source":"PubMed","ids":["2426499","27990002","540881","540882"],"urls":["http://europepmc.org/abstract/MED/2426499","http://europepmc.org/abstract/MED/27990002","http://europepmc.org/abstract/MED/540881","http://europepmc.org/abstract/MED/540882"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Bacterial 70S ribosome inhibitor","chemblIds":["CHEMBL2218877","CHEMBL2220427"],"targetName":"Bacterial 70S ribosome","targetType":"protein nucleic-acid complex","targets":[],"references":[{"source":"PubMed","ids":["20876130"],"urls":["http://europepmc.org/abstract/MED/20876130"]},{"source":"DailyMed","ids":["setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9a63da11-01be-4c63-a260-e6bdbb4a7a69"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","chemblIds":["CHEMBL3545365"],"targetName":"Hepatocyte growth factor receptor","targetType":"single protein","targets":["ENSG00000105976"],"references":[{"source":"Other","ids":["http://www.deciphera.com/pipeline","http://www.deciphera.com/pipeline","http://www.deciphera.com/pipeline","http://www.deciphera.com/pipeline"],"urls":["http://www.deciphera.com/pipeline","http://www.deciphera.com/pipeline","http://www.deciphera.com/pipeline","http://www.deciphera.com/pipeline"]},{"source":"PubMed","ids":["26285778","26285778","26285778","26285778"],"urls":["http://europepmc.org/abstract/MED/26285778","http://europepmc.org/abstract/MED/26285778","http://europepmc.org/abstract/MED/26285778","http://europepmc.org/abstract/MED/26285778"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Sodium/glucose cotransporter 2 inhibitor","chemblIds":["CHEMBL429910"],"targetName":"Sodium/glucose cotransporter 2","targetType":"single protein","targets":["ENSG00000140675"],"references":[{"source":"DailyMed","ids":["setid=fc6ae30e-868b-4ac9-b69d-900922503998"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fc6ae30e-868b-4ac9-b69d-900922503998"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cytochrome P450 19A1 inhibitor","chemblIds":["CHEMBL1399"],"targetName":"Cytochrome P450 19A1","targetType":"single protein","targets":["ENSG00000137869"],"references":[{"source":"DailyMed","ids":["setid=03586c40-eb32-45c5-beb7-6762a6b78790#section-12"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=03586c40-eb32-45c5-beb7-6762a6b78790#section-12"]}]}
{"actionType":"POSITIVE ALLOSTERIC MODULATOR","mechanismOfAction":"GABA-A receptor; anion channel positive allosteric modulator","chemblIds":["CHEMBL13280"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"PubMed","ids":["23590909","24190785","26733466"],"urls":["http://europepmc.org/abstract/MED/23590909","http://europepmc.org/abstract/MED/24190785","http://europepmc.org/abstract/MED/26733466"]},{"source":"Other","ids":["http://ac.els-cdn.com/S030645221000014X/1-s2.0-S030645221000014X-main.pdf?_tid=cb93cab0-992f-11e7-968e-00000aab0f02&acdnat=1505381801_97898d073d95c93053623c2eab5c8133"],"urls":["http://ac.els-cdn.com/S030645221000014X/1-s2.0-S030645221000014X-main.pdf?_tid=cb93cab0-992f-11e7-968e-00000aab0f02&acdnat=1505381801_97898d073d95c93053623c2eab5c8133"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor receptor inhibitor","chemblIds":["CHEMBL3545358"],"targetName":"Vascular endothelial growth factor receptor","targetType":"protein family","targets":["ENSG00000102755","ENSG00000037280","ENSG00000128052"],"references":[{"source":"Other","ids":["http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf","http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086","http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf","http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086"],"urls":["http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf","http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086","http://www.4sc.de/sites/default/files/documents/4SC-203-Poster-ECCO-Stockholm-2011.pdf","http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=666086"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Androgen Receptor antagonist","chemblIds":["CHEMBL806"],"targetName":"Androgen Receptor","targetType":"single protein","targets":["ENSG00000169083"],"references":[{"source":"FDA","ids":["label/2001/18554s23lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2001/18554s23lbl.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"C-C chemokine receptor type 2 antagonist","chemblIds":["CHEMBL3545032"],"targetName":"C-C chemokine receptor type 2","targetType":"single protein","targets":["ENSG00000121807"],"references":[{"source":"Other","ids":["http://www.pfizer.com/research/science_and_technology/product_pipeline","http://www.pfizer.com/research/science_and_technology/product_pipeline"],"urls":["http://www.pfizer.com/research/science_and_technology/product_pipeline","http://www.pfizer.com/research/science_and_technology/product_pipeline"]}]}
{"actionType":"SEQUESTERING AGENT","mechanismOfAction":"Phosphate sequestering agent","chemblIds":["CHEMBL4297751"],"references":[{"source":"Other","ids":["https://academic.oup.com/ckj/article/8/2/161/470070"],"urls":["https://academic.oup.com/ckj/article/8/2/161/470070"]},{"source":"PubMed","ids":["19158369"],"urls":["http://europepmc.org/abstract/MED/19158369"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","chemblIds":["CHEMBL3813873"],"targetName":"Tyrosine-protein kinase receptor FLT3","targetType":"single protein","targets":["ENSG00000122025"],"references":[{"source":"FDA","ids":["label/2019/211810s000lbl.pdf","label/2019/211810s000lbl.pdf","label/2019/211810s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/211810s000lbl.pdf"]},{"source":"PubMed","ids":["22039576","25847190","22039576","25847190","22039576","25847190"],"urls":["http://europepmc.org/abstract/MED/22039576","http://europepmc.org/abstract/MED/25847190","http://europepmc.org/abstract/MED/22039576","http://europepmc.org/abstract/MED/25847190","http://europepmc.org/abstract/MED/22039576","http://europepmc.org/abstract/MED/25847190"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatitis C virus serine protease, NS3/NS4A inhibitor","chemblIds":["CHEMBL3707372"],"targetName":"Hepatitis C virus serine protease, NS3/NS4A","targetType":"protein complex","targets":[],"references":[{"source":"FDA","ids":["label/2017/209195s002lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209195s002lbl.pdf"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Toxin A binding agent","chemblIds":["CHEMBL2108655"],"targetName":"Toxin A","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["16838228","17206941","18341677","16838228","17206941","18341677"],"urls":["http://europepmc.org/abstract/MED/16838228","http://europepmc.org/abstract/MED/17206941","http://europepmc.org/abstract/MED/18341677","http://europepmc.org/abstract/MED/16838228","http://europepmc.org/abstract/MED/17206941","http://europepmc.org/abstract/MED/18341677"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cytochrome P450 3A4 inhibitor","chemblIds":["CHEMBL281764"],"targetName":"Cytochrome P450 3A4","targetType":"single protein","targets":["ENSG00000160868"],"references":[{"source":"Wikipedia","ids":["Tabimorelin","Tabimorelin"],"urls":["http://en.wikipedia.org/wiki/Tabimorelin","http://en.wikipedia.org/wiki/Tabimorelin"]},{"source":"PubMed","ids":["12610745","10427162","11032702"],"urls":["http://europepmc.org/abstract/MED/12610745","http://europepmc.org/abstract/MED/10427162","http://europepmc.org/abstract/MED/11032702"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL278172"],"references":[{"source":"PubMed","ids":["22641643","24745839","24992293"],"urls":["http://europepmc.org/abstract/MED/22641643","http://europepmc.org/abstract/MED/24745839","http://europepmc.org/abstract/MED/24992293"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Angiopoietin-2 inhibitor","chemblIds":["CHEMBL2109586"],"targetName":"Angiopoietin-2","targetType":"single protein","targets":["ENSG00000091879"],"references":[{"source":"PubMed","ids":["27076631","27076631"],"urls":["http://europepmc.org/abstract/MED/27076631","http://europepmc.org/abstract/MED/27076631"]}]}
{"actionType":"DISRUPTING AGENT","mechanismOfAction":"DNA disrupting agent","chemblIds":["CHEMBL1652128"],"references":[{"source":"PubMed","ids":["19223649","19223649"],"urls":["https://pubmed.ncbi.nlm.nih.gov/19223649/","https://pubmed.ncbi.nlm.nih.gov/19223649/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Penicillin-binding protein inhibitor","chemblIds":["CHEMBL1200388","CHEMBL891"],"targetName":"Penicillin-binding protein","targetType":"protein family","targets":[],"references":[{"source":"Wikipedia","ids":["Cloxacillin","DD-transpeptidase"],"urls":["http://en.wikipedia.org/wiki/Cloxacillin","http://en.wikipedia.org/wiki/DD-transpeptidase"]},{"source":"PubMed","ids":["15631796"],"urls":["http://europepmc.org/abstract/MED/15631796"]},{"source":"ISBN","ids":["0-86577-843-4 PP. 270"],"urls":["http://www.isbnsearch.org/isbn/0865778434"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Glycoprotein inhibitor","chemblIds":["CHEMBL1743021"],"targetName":"Glycoprotein","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["15994800"],"urls":["http://europepmc.org/abstract/MED/15994800"]}]}
{"mechanismOfAction":"Antioxidant and metal chelator","chemblIds":["CHEMBL4297510"],"references":[{"source":"ClinicalTrials","ids":["NCT03123692","NCT04092205"],"urls":["https://clinicaltrials.gov/ct2/show/NCT03123692","https://clinicaltrials.gov/ct2/show/NCT04092205"]},{"source":"EMA","ids":["https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3171864"],"urls":["https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3171864"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Norepinephrine transporter inhibitor","chemblIds":["CHEMBL169901"],"targetName":"Norepinephrine transporter","targetType":"single protein","targets":["ENSG00000103546"],"references":[{"source":"PubMed","ids":["4152315","4544694","5520376","5788526","619932","837136"],"urls":["http://europepmc.org/abstract/MED/4152315","http://europepmc.org/abstract/MED/4544694","http://europepmc.org/abstract/MED/5520376","http://europepmc.org/abstract/MED/5788526","http://europepmc.org/abstract/MED/619932","http://europepmc.org/abstract/MED/837136"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Hepatocyte growth factor receptor inhibitor","chemblIds":["CHEMBL3188267"],"targetName":"Hepatocyte growth factor receptor","targetType":"single protein","targets":["ENSG00000105976"],"references":[{"source":"Other","ids":["http://cancerres.aacrjournals.org/content/68/9_Supplement/2577","http://clincancerres.aacrjournals.org/content/early/2011/09/14/1078-0432.CCR-11-1157.full.pdf","http://www.novartisoncology.com/ct/pipelineDetails?compound=INC280&diseaseAcr=NSCLC"],"urls":["http://cancerres.aacrjournals.org/content/68/9_Supplement/2577","http://clincancerres.aacrjournals.org/content/early/2011/09/14/1078-0432.CCR-11-1157.full.pdf","http://www.novartisoncology.com/ct/pipelineDetails?compound=INC280&diseaseAcr=NSCLC"]}]}
{"actionType":"CHELATING AGENT","mechanismOfAction":"Heavy metals chelating agent","chemblIds":["CHEMBL1597"],"references":[{"source":"DailyMed","ids":["setid=bee9a137-160f-47e8-a551-ca461ae4f51e#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bee9a137-160f-47e8-a551-ca461ae4f51e#nlm34090-1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Ferriprotoporphyrin IX inhibitor","chemblIds":["CHEMBL566534"],"references":[{"source":"Wikipedia","ids":["Artemether","Hemozoin"],"urls":["http://en.wikipedia.org/wiki/Artemether","http://en.wikipedia.org/wiki/Hemozoin"]},{"source":"DailyMed","ids":["setid=7866ec19-dfac-47d4-a53f-511a12643cbf#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7866ec19-dfac-47d4-a53f-511a12643cbf#section-13"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase AKT inhibitor","chemblIds":["CHEMBL3137336"],"targetName":"Serine/threonine-protein kinase AKT","targetType":"protein family","targets":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"references":[{"source":"PubMed","ids":["24978597"],"urls":["http://europepmc.org/abstract/MED/24978597"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Sodium/glucose cotransporter 2 inhibitor","chemblIds":["CHEMBL4297658"],"targetName":"Sodium/glucose cotransporter 2","targetType":"single protein","targets":["ENSG00000140675"],"references":[{"source":"Other","ids":["https://www.pmda.go.jp/files/000230401.pdf"],"urls":["https://www.pmda.go.jp/files/000230401.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Sodium/potassium-transporting ATPase inhibitor","chemblIds":["CHEMBL3545057"],"targetName":"Sodium/potassium-transporting ATPase","targetType":"protein complex group","targets":["ENSG00000163399","ENSG00000129244","ENSG00000143153","ENSG00000018625","ENSG00000069849","ENSG00000105409","ENSG00000132681","ENSG00000137731"],"references":[{"source":"ISBN","ids":["9780702034718 PP. 258"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"PubMed","ids":["13345619","23537048"],"urls":["http://europepmc.org/abstract/MED/13345619","http://europepmc.org/abstract/MED/23537048"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"von Willebrand factor inhibitor","chemblIds":["CHEMBL2108339"],"targetName":"von Willebrand factor","targetType":"single protein","targets":["ENSG00000110799"],"references":[{"source":"PubMed","ids":["19479665"],"urls":["https://pubmed.ncbi.nlm.nih.gov/19479665/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase ABL inhibitor","chemblIds":["CHEMBL4130229"],"targetName":"Tyrosine-protein kinase ABL","targetType":"single protein","targets":["ENSG00000097007"],"references":[{"source":"Other","ids":["https://ashpublications.org/blood/article/136/Supplement%201/51/470418/Phase-1-Trial-of-Vodobatinib-a-Novel-Oral-BCR-ABL1","https://ashpublications.org/blood/article/136/Supplement%201/51/470418/Phase-1-Trial-of-Vodobatinib-a-Novel-Oral-BCR-ABL1"],"urls":["https://ashpublications.org/blood/article/136/Supplement%201/51/470418/Phase-1-Trial-of-Vodobatinib-a-Novel-Oral-BCR-ABL1","https://ashpublications.org/blood/article/136/Supplement%201/51/470418/Phase-1-Trial-of-Vodobatinib-a-Novel-Oral-BCR-ABL1"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Fibroblast growth factor receptor inhibitor","chemblIds":["CHEMBL270995"],"targetName":"Fibroblast growth factor receptor","targetType":"protein family","targets":["ENSG00000068078","ENSG00000077782","ENSG00000160867","ENSG00000066468"],"references":[{"source":"PubMed","ids":["18288793","18829493","18288793","18829493"],"urls":["http://europepmc.org/abstract/MED/18288793","http://europepmc.org/abstract/MED/18829493","http://europepmc.org/abstract/MED/18288793","http://europepmc.org/abstract/MED/18829493"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Reverse transcriptase inhibitor","chemblIds":["CHEMBL4650447"],"targetName":"Reverse transcriptase","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["33040075","25144636","25144636"],"urls":["https://pubmed.ncbi.nlm.nih.gov/33040075/","https://pubmed.ncbi.nlm.nih.gov/25144636/","https://pubmed.ncbi.nlm.nih.gov/25144636/"]}]}
